Aggregated News From Investment Management Regulators

Press release on the suspension of trading in Acacia Pharma

FSMA BE

Report/Flag

Please complete the required fields.



ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017

Trading in the financial instruments of Acacia Pharma, ISIN GB00BYWF9Y76, on Euronext Brussels is suspended from 18/02/2021 at 11:25 CET until the publication of a press release.

This news item was originally published by the Financial Services and Markets Authority (FSMA BE). For more information, please see the Source Link.

Return Home

Regulator Information

Regulator Name: Financial Services and Markets Authority
Abbreviation: FSMA
Jurisdiction: Belgium
Website: https://www.fsma.be/en/
More Information

Recent Articles

SEC Seeks Emergency Relief to Ensure Binance.US Customers’ Assets are Protected

SEC US 0
The Securities and Exchange Commission today filed an emergency action application seeking a temporary restraining order freezing assets, directing defendants to repatriate assets held for the benefi
Read more

SEC.gov | HOME

SEC US 0
The Ombudsman will listen to your inquiries, complaints, and issues, review the information you provide, and help identify procedures, options, and resources.
Read more

Updated Agenda for the June 7 Open Commission Meeting

CFTC US 0

Read more

SEC Charges Coinbase for Operating as an Unregistered Securities Exchange, Broker, and Clearing Agency

SEC US 0
Coinbase also charged for the unregistered offer and sale of securities in connection with its staking-as-a-service program. The Securities and Exchange Commission today charged Coinbase, Inc.
Read more

ESMA publishes follow-up report to the peer review on the Guidelines on ETFs and other UCITS issues

ESMA 0
See the content published by the European Securities and Markets Authority (ESMA) here: Read more

Get the latest from Regulatory.News in your inbox!

×

© Copyright 2023- Regulatory.News